Comparative evaluation of cefazolin and cephalothin in children.
D000038:Abscess / Q000188:drug therapy; D000293:Adolescent; D001419:Bacteria / Q000302:isolation & purification; D002481:Cellulitis / Q000188:drug therapy; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D002512:Cephalothin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007239:Infections / Q000188:drug therapy* / Q000382:microbiology; D007275:Injections, Intravenous; D008199:Lymphadenitis / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy; D013210:Staphylococcus / Q000302:isolation & purification; D013440:Sulfides / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use; D013830:Thiadiazoles / Q000627:therapeutic use
D002511:Cephalosporins; D013440:Sulfides; D013777:Tetrazoles; D013830:Thiadiazoles; D002512:Cephalothin